Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin topoproteome under Humira treatment in psoriasis
2010-018279-99Phase 4Completed
- Sponsor
- Otto von Guericke University Magdeburg
- Start
- Jan 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in psoriasis, sponsored by Otto von Guericke University Magdeburg. Primary endpoint: Antipsoriatic treatment response at week 16. Started Jan 2010; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2010-018279-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018279-99.